The Indian government sent a notice March 3 that it is halting exports of 13 active pharmaceutical ingredients and 13 finished drug products due to concerns about the coronavirus outbreak causing shortages.
The Indian Pharmaceutical Alliance, which represents India’s largest drugmakers, and the Indian Drug Manufacturers’ Association wrote to the government asking to withdraw the restriction, saying the country has a “surplus to meet global demand” for the ingredients and finished drug products and that the restriction hurts the country’s image.
At a meeting March 9, drugmakers reportedly assured the government that they have enough supplies to last until at least May, the Economic Times reported.
The drug industry added that if any unexpected shortages occur, they’ll agree to restrict exports again.
Read the full article here.
More articles on pharmacy:
Coronavirus prompts fear of respiratory drug shortage
Bristol Myers Squibb reveals new branding after Celgene acquisition
Online pharmacy to offer 500 generic drugs for $5 monthly, delivery included
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
